![Alexandra Dambeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexandra Dambeck
Directeur Financier/CFO chez
SPRINGER NATURE AG & CO. KGAA
Profil
Alexandra Dambeck currently works at Springer Nature AG & Co. KGaA, as CFO & Deputy Chairman-Management Board.
Ms. Dambeck also formerly worked at Fresenius Medical Care Ventures GmbH, as Managing Director from 2016 to 2020 and Fresenius Medical Care AG, as Head-Corporate Controlling & Corporate Accounting.
Postes actifs de Alexandra Dambeck
| Sociétés | Poste | Début |
|---|---|---|
| SPRINGER NATURE AG & CO. KGAA | Directeur Financier/CFO | - |
Anciens postes connus de Alexandra Dambeck
| Sociétés | Poste | Fin |
|---|---|---|
Fresenius Medical Care Ventures GmbH
 Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Directeur/Membre du Conseil | 31/12/2020 |
| FRESENIUS MEDICAL CARE AG | Comptroller/Controller/Auditor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Fresenius Medical Care AG
 Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products | Health Services |
Fresenius Medical Care Ventures GmbH
Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Finance |
Springer Nature AG & Co. KGaA
 Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Publishes trade journals | Consumer Services |
